MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Neural correlates of Level-1 and Level-2 diagnostic criteria for Mild Cognitive Impairment in Parkinson´s disease.

    I. Aracil-Bolaños, F. Sampedro, J. Marín-Lahoz, A. Horta-Barba, S. Martínez-Horta, JM. González-de-Echávarri, J. Pérez-Pérez, H. Bejr-Kasem, B. Pascual-Sedano, MA. Boti, A. Campolongo, C. Izquierdo, A. Gironell, B. Gómez-Ansón, J. Pagonabarraga, J. Kulisevksy (Barcelona, Spain)

    Objective: To profile the neural correlates of neuropsychological assessment according to the Movement Disorders Society Task Force Criteria in its Level-1 and Level-2 recommendations Background:…
  • 2019 International Congress

    Distinct neuronal correlates underpin impulsive action and impulsive choice in Tourette disorder

    C. Atkinson-Clement, A. de Liege, C. Porte, Y. Klein-Koerkamp, B. Beranger, A. Hartmann, Y. Worbe (Paris, France)

    Objective: (i) Evaluate cognitive impulsivity in Tourette disorder (TD), (ii) identify neuronal correlates of cognitive impulsivity. Background: TD is characterized by motor and vocal tics,…
  • 2019 International Congress

    Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

    M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)

    Objective: The aim of this study was to compare the efficiency  of the short form of Montreal Cognitive Assessment (s-MoCa) which has been validated in…
  • 2019 International Congress

    Cognitive Profile of Patients with Parkinson´s Disease and Subthalamic Nucleus Deep Brain Stimulation

    E. Barbosa, J. Santos, H. Fichman (Rio de Janeiro, Brazil)

    Objective: Compare the ON and OFF cognitive performance of patients with PD receiving Subthalamic nucleus Deep Brain Stimulation (STN-DBS) using a computerized neuropsycological battery called…
  • 2019 International Congress

    Levodopa Effects on Visuospatial Working Memory in Parkinson’s Disease

    E. Bayram, I. Litvan, B. Wright, C. Grembowski, D. Harrington (La Jolla, CA, USA)

    Objective: To investigate the effects of levodopa on memory load and distractor resistance during visuospatial working memory (WM) in Parkinson’s disease (PD). Background: Visuospatial WM…
  • 2019 International Congress

    Validation of a novel quotient differentiating cognitive and motor-driven activity of daily living impairments in PD patients

    S. Becker, C. Pauly, M. Lawton, G. Hipp, F. Bowring, P. Sulzer, M. Hu, R. Krüger, I. Liepelt-Scarfone (Tübingen, Germany)

    Objective: To validate novel scores assessing cognitive-driven activity of daily living (ADL) dysfunction in a large, international pooled non-demented Parkinson’s disease (PD) cohort. Background: The…
  • 2019 International Congress

    Brain amyloid contribution to cognitive dysfunction in Lewy bodies disorders: a pilot study

    R. Biundo, E. Fiorenzato, D. Cecchin, C. Salvotti, L. Weis, A. Antonini (Venice, Italy)

    Objective: To investigate regional [18F]florbetapir binding to amyloid-β and its contribution to cognitive dysfunction in Lewy bodies disorders. Background: Lewy bodies disorders like Parkinson’s disease…
  • 2019 International Congress

    Higher probability of prodromal Parkinson’s disease is related to lower performance in all cognitive domains

    A. Bougea, M. Maraki, M. Yannakoulia, M. Stamelou, G. Xiromerisiou, M. Kosmidis, E. Dardiotis, G. Hadjigeorgiou, P. Sakka, C. Anastasiou, L. Stefanis, N. Scarmeas (Athens, Greece)

    Objective: to assess prodromal Parkinson disease (PD) probability and relate it to detailed cognitive performance in a community cohort. Background: There is a limited information…
  • 2019 International Congress

    Visuoperceptual impairment: a key feature in the diagnosis of corticobasal degeneration

    R. Bruffaerts, K. van Bouwel, PH. van Damme, K. Claeys, K. van Laere (Leuven, Belgium)

    Objective: We present a patient with a neurodegenerative disease where visuoperceptual testing led to a new working diagnosis of corticobasal degeneration (CBD) Background: CBD is a…
  • 2019 International Congress

    The cognitive profile associated with mild parkinsonian signs in a British Birth Cohort at age 69-71

    S. Buchanan, C. Lane, K. Lu, T. Parker, S. James, A. Keshavan, S. Keuss, H. Murray-Smith, A. Wong, D. Cash, W. Coath, S. Crutch, N. Fox, M. Richards, A. Schrag, J. Schott (London, United Kingdom)

    Objective: To test associations between mild parkinsonian signs (MPS), cognitive function and brain pathologies in Insight 46, a subsample of the MRC National Survey of…
  • « Previous Page
  • 1
  • …
  • 1138
  • 1139
  • 1140
  • 1141
  • 1142
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley